Sarepta Therapeutics is a biopharmaceutical company developing RNA-targeted therapeutics that addres serious and life-threatening diseases including Duchenne muscular dystrophy and infectious diseases such as influenza, and the Ebola virus.
2025/2/1 11:09:02
(SRPT:NASDAQ)
Newsletter coverage
Streetwise Reports Articles